4//SEC Filing
Kelderman Kim 4
Accession 0001062993-25-001237
CIK 0000842023other
Filed
Jan 28, 7:00 PM ET
Accepted
Jan 29, 4:35 PM ET
Size
33.1 KB
Accession
0001062993-25-001237
Insider Transaction Report
Form 4
BIO-TECHNE CorpTECH
Kelderman Kim
DirectorChief Executive Officer
Transactions
- Exercise/Conversion
Common Stock
2025-01-27$37.70/sh+13,392$504,878→ 52,396 total - Sale
Common Stock
2025-01-27$77.19/sh−11,731$905,533→ 40,665 total - Sale
Common Stock
2025-01-27$77.95/sh−1,661$129,480→ 39,004 total - Exercise/Conversion
Stock Option (Right to Buy)
2025-01-27−13,392→ 0 totalExercise: $37.70Exp: 2025-05-01→ Common Stock (13,392 underlying)
Holdings
- 25,945
Performance Stock Options (Right to Buy)
Exercise: $68.54Exp: 2031-02-01→ Common Stock (25,945 underlying) - 51,890
Stock Options (Right to Buy)
Exercise: $68.54Exp: 2031-02-01→ Common Stock (51,890 underlying) - 51,261
Performance Restricted Stock Units
→ Common Stock (51,261 underlying) - 69,061
Stock Options (Right to Buy)
Exercise: $74.91Exp: 2034-08-15→ Common Stock (69,061 underlying) - 8,873
Performance Restricted Stock Units
→ Common Stock (8,873 underlying) - 84,308
Stock Option (Right to Buy)
Exercise: $44.33Exp: 2025-08-08→ Common Stock (84,308 underlying) - 115,724
Stock Option (Right to Buy)
Exercise: $66.97Exp: 2027-08-05→ Common Stock (115,724 underlying) - 25,944
Stock Option (Right to Buy)
Exercise: $120.46Exp: 2028-08-06→ Common Stock (25,944 underlying) - 21,704
Performance Stock Options (Right to Buy)
Exercise: $94.52Exp: 2029-08-15→ Common Stock (21,704 underlying) - 28,940
Stock Options (Right to Buy)
Exercise: $94.52Exp: 2029-08-15→ Common Stock (28,940 underlying) - 25,630
Restricted Stock Units
→ Common Stock (25,630 underlying) - 109,536
Stock Option (Right to Buy)
Exercise: $47.60Exp: 2026-08-07→ Common Stock (109,536 underlying) - 6,984
Performance Restricted Stock Units
→ Common Stock (6,984 underlying) - 23,881
Performance Stock Options (Right to Buy)
Exercise: $84.61Exp: 2030-08-15→ Common Stock (23,881 underlying) - 29,391
Stock Options (Right to Buy)
Exercise: $84.61Exp: 2030-08-15→ Common Stock (29,391 underlying) - 38,252
Stock Options (Right to Buy)
Exercise: $52.83Exp: 2030-11-01→ Common Stock (38,252 underlying) - 9,423
Performance Restricted Stock Units
→ Common Stock (9,423 underlying)
Footnotes (14)
- [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $76.67 to $77.66 inclusive. The reporting person undertakes to provide Bio-Techne Corporation, any security holder of Bio-Techne Corporation, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F10]Options to purchase 9,563 shares vest on each of 11/1/2024, 11/1/2025, 11/1/2026 and 11/1/2027.
- [F11]Options to purchase 12,973 shares vest on each of 2/1/2025 and 2/1/2027, and options to purchase 12,972 shares vest on each of 2/1/2026 and 2/1/2028.
- [F12]Vests in full or in part on 8/15/2027 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
- [F13]8,543 restricted stock units vest on each of 8/15/2025 and 8/15/2026, and 8,544 restricted stock units vest on 8/15/2027.
- [F14]Options to purchase 17,265 shares vest on each of 8/15/2025, 8/15/2026 and 8/15/2027, and options to purchase 17,266 shares vest on 8/15/2028.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $77.69 to $78.08 inclusive. The reporting person undertakes to provide Bio-Techne Corporation, any security holder of Bio-Techne Corporation, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F3]Fully exercisable.
- [F4]Options to purchase 6,484 shares vest on each of 8/6/2022 and 8/6/2023 and options to purchase 6,488 shares vest on each of 8/6/2024 and 8/6/2025.
- [F5]Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock.
- [F6]Vests in full or in part on 8/15/2025 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
- [F7]Options to purchase 7,236 shares vest on each of 8/15/2023, 8/15/2024 and 8/15/2026 and options to purchase 7,232 shares vest on 8/15/2025.
- [F8]Vests in full or in part on 8/15/2026 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
- [F9]Options to purchase 7,348 shares vest on each of 8/15/2024, 8/15/2025 and 8/15/2027 and options to purchase 7,347 shares vest on 8/15/2026.
Issuer
BIO-TECHNE Corp
CIK 0000842023
Entity typeother
Related Parties
1- filerCIK 0001739054
Filing Metadata
- Form type
- 4
- Filed
- Jan 28, 7:00 PM ET
- Accepted
- Jan 29, 4:35 PM ET
- Size
- 33.1 KB